Viibryd Reviews: The maker of Viibryd is attempting to extend the antidepressant’s patent. Forest Pharmaceuticals is planning to extend the patent on Viibryd, the first new antidepressant authorized by the FDA in a decade. Viibryd (vilazodone hydrochloride) is used to treat major depressive disorder (MDD). The patent will expire in […]
Viibryd Reviews
1 post